Curcumin may be promising treatment for cancer
the ONA take:
Curcumin, a compound found in turmeric, may be a promising treatment for a variety of cancers and other inflammatory diseases, according to an international review published in Molecules.
Gautam Sethi, PhD, of Curtin University in Australia looked at past clinical trials that used curcumin in patients with cancer and concluded that it was a safe and effective method of treating cancer.
“To treat cancer you need multi-targeted agents, better than mono-targeted agents, which have been used for the past few years,” Dr. Sethi said. “They are more effective in treating cancer as it has been found that several genes are mutated in a given cancer.”
Oncogenic genes, he claimed, can be deregulated in cancer using curcumin. Therefore, it is effective for patients with multiple myeloma and those with fatal pancreatic cancer, for which there are no drug treatments.
Curcumin counteracts the effects of cyclophosphamide, however, and is therefore not as effective in patients undergoing breast cancer treatment.
Dr. Sethi recommends that people use turmeric more often in everyday cooking.
Curcumin, a compound found in turmeric, may be a promising treatment for a variety of cancers.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|